© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
You are one of 7.5 million annual visitors to OpenSecrets. If you each donated just $1 a year, we'd never worry about funding again.
The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug ...
Cephalon and Ception Therapeutics have entered into an agreement that provides Cephalon with an option to purchase all outstanding capital stock of Ception. Ception's lead drug is reslizumab, a ...
The European Commission's Antitrust unit cleared Friday the acquisition of US-based pharmaceutical company Cephalon Inc. (CEPH) by the generic pharmaceutical company Teva Pharmaceuticals ...
Cephalon Inc did not make direct contributions to any member of a congressional committee in the 2024 election cycle. Feel free to distribute or cite this material, but please credit OpenSecrets. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback